STIM

Neuronetics Inc

STIM.US neurostar.com
3.03
+0.02 (+0.66%)
USD · NASDAQ
52-week range
0.80
3.44
Trading at 84% of the 52-week range
Market Cap
230.88M
P/E Ratio
0.00
Forward P/E
0.00
Book Value
0.23
Div. Yield
N/A
% Institutions
54.00%
% Insiders
30.85%

1 Year

-12.4%

3 Year

+104.7%

10 Year

-89.1%
Description

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Company Information

Company Name
Neuronetics Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US64131A1051
CIK: 0001227636
CUSIP: 64131A105
Currency: USD
Full Time Employees: 658
Phone: 877 600 7555
Fiscal Year End: December
IPO Date: Jun 28, 2018
Description:

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Address:

3222 Phoenixville Pike, Malvern, PA, United States, 19355

People

Directors & Officers

Name Title Year Born
Mr. Daniel L. Reuvers CEO, President & Director 1963
Mr. Nir Naor C.F.A., CPA, L.L.M., M.B.A. Executive VP, CFO, Corporate Secretary, Principal Financial and Accounting Officer & Treasurer 1975
Mr. Robert Greene Senior Vice President of Sales NA
Mr. Cory S. Anderson Executive Vice President & General Manager of Greenbrook 1977

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 20, 2026 Jorey Chernett N/A Purchase 100.00K $1.58 $158.00K
Mar 20, 2026 Jorey Chernett N/A Purchase 169.47K $1.41 $238.96K
Mar 19, 2026 Jorey Chernett N/A Purchase 450.00K $1.33 $598.50K
Mar 19, 2026 Keith J Sullivan N/A Sale 46.29K $1.34 $62.03K
Mar 19, 2026 Steven Pfanstiel N/A Sale 16.43K $1.34 $22.02K
Mar 19, 2026 William Andrew Macan N/A Sale 16.01K $1.34 $21.45K
Mar 18, 2026 Jorey Chernett N/A Purchase 607.40K $1.35 $819.99K
Mar 17, 2026 Jorey Chernett N/A Purchase 531.00K $1.16 $615.96K
Feb 26, 2026 Keith J Sullivan N/A Sale 8.45K $1.35 $11.41K
Feb 26, 2026 William Andrew Macan N/A Sale 3.43K $1.35 $4.63K
Feb 12, 2026 Keith J Sullivan N/A Sale 33.85K $1.65 $55.85K
Feb 12, 2026 William Andrew Macan N/A Sale 14.12K $1.65 $23.30K
Feb 10, 2026 Keith J Sullivan N/A Sale 40.98K $1.55 $63.51K
Feb 10, 2026 William Andrew Macan N/A Sale 3.49K $1.55 $5.40K
May 12, 2025 Stephen Furlong N/A Sale 193.46K $4.27 $826.07K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Madryn Asset Management, LP 18.54M Jun 30, 2026 24.33% $65.29 0.35%
UBS Group AG 2.87M Mar 31, 2026 3.77% $0.00 10.11%
Balyasny Asset Management LLC 2.74M Mar 31, 2026 3.60% $0.01 7.50%
BlackRock Inc 2.32M Mar 31, 2026 3.04% $0.00 -1.50%
Vanguard Capital Management, LLC 2.05M Mar 31, 2026 2.69% $0.00 0.00%
Lane Generational LLC 1.77M Mar 31, 2026 2.33% $2.05 4.07%
FourWorld Capital Management LLC 1.74M Jun 30, 2026 2.29% $2.06 17.11%
Masters Capital Management LLC 1.00M Jun 30, 2026 1.31% $0.03 0.00%
Geode Capital Management, LLC 958.99K Mar 31, 2026 1.26% $0.00 7.54%
State Street Corp 842.55K Mar 31, 2026 1.11% $0.00 44.23%
AdvisorShares Investments, LLC 742.80K Jun 30, 2026 0.97% $0.12 20.35%
Ikarian Capital, LLC 701.18K Mar 31, 2026 0.92% $0.08 0.00%
Wexford Capital LP 700.96K Mar 31, 2026 0.92% $0.15 8.68%
HighTower Advisors, LLC 562.37K Mar 31, 2026 0.74% $0.00 -0.34%
Northern Trust Corp 277.38K Mar 31, 2026 0.36% $0.00 -0.37%
Dauntless Investment Group, LLC 269.21K Mar 31, 2026 0.35% $0.26 67.29%
Vanguard Fiduciary Trust Co 258.03K Mar 31, 2026 0.34% $0.00 0.00%
The Goldman Sachs Group Inc 233.59K Mar 31, 2026 0.31% $0.00 -29.63%
JBF Capital, Inc. 233.17K Mar 31, 2026 0.31% $0.05 0.00%
Vanguard Portfolio Management, LLC 221.17K Mar 31, 2026 0.29% $0.00 0.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard MStar Total Stk Mkt Idx Invest 1.06M 1.39% ▲ 0.00% Jul 31, 2026
2 AdvisorShares Psychedelics ETF 864.50K 1.13% ▲ 0.00% Aug 31, 2026
3 Vanguard Institutional Extnd Mkt Idx Tr 478.96K 0.63% ▲ 12.88% Jul 31, 2026
4 Fidelity Extended Market Index 199.80K 0.26% ▼ 3.63% Jul 31, 2026
5 Extended Equity Market Fund B 109.79K 0.14% ▲ 0.00% Dec 31, 2025
6 Extended Equity Market Fund E 109.79K 0.14% ▲ 0.00% Dec 31, 2025
7 Blackrock Extended Mkt Fund CF 109.29K 0.14% ▲ 0.00% May 31, 2026
8 iShares Micro-Cap ETF 92.88K 0.12% ▼ 1.95% Aug 31, 2026
9 BlackRock Extended Equity Market Fund K 92.88K 0.12% ▼ 0.20% Jun 30, 2026
10 Goldman Sachs Absolute Ret Trckr Instl 87.05K 0.11% ▲ 119.24% Jun 30, 2026

Financial Highlights

Market Cap: $230.88M
EBITDA: $-19.26M
Book Value: $0.23
Earnings/Share: $-0.43
Profit Margin: -19.62%
Operating Margin: -3.61%
ROA (TTM): -10.55%
ROE (TTM): -116.10%
Revenue (TTM): $155.10M
Revenue/Share (TTM): $2.23
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 9.10%

Valuation Metrics

Enterprise Value: $296.45M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 76.20M
Shares Float: 37.15M
% Insiders: 30.85%
% Institutions: 54.00%
Short % Float: 16.28%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$149.16M
Cost of Goods Sold
adjust
$-76.85M
Gross Profit
subtotal
$72.31M
SG&A
adjust
$-49.70M
R&D
adjust
$-6.58M
Other Operating Expense
adjust
$-47.46M
Operating Income
subtotal
$-31.44M
Other / Non-Operating Items
adjust
$-7.56M
Net Income
subtotal
$-39.00M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about STIM.US!